Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial (Q41701305)
Jump to navigation
Jump to search
scientific article published on 14 October 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial |
scientific article published on 14 October 2014 |
Statements
1 reference
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial (English)
1 reference
Shizuka Kaneko
1 reference
Francis Chow
1 reference
Dong Seop Choi
1 reference
Shinji Taneda
1 reference
Koichi Hirao
1 reference
Yongsoo Park
1 reference
Thomas Hasseriis Andersen
1 reference
Mari-Anne Gall
1 reference
Jens Sandahl Christiansen
1 reference
BOOST: Intensify All Trial Investigators
1 reference
14 October 2014
1 reference
1 reference
Identifiers
1 reference